Matches in SemOpenAlex for { <https://semopenalex.org/work/W2066883487> ?p ?o ?g. }
Showing items 1 to 87 of
87
with 100 items per page.
- W2066883487 endingPage "382" @default.
- W2066883487 startingPage "377" @default.
- W2066883487 abstract "<h2>Abstract</h2> The 5-year survival rates for patients undergoing a potentially curative surgical resection for pre-operatively identified stage 3A N2 non-small cell lung cancer (NSCLC) vary from 2–13%. In an attempt to improve the curative potential of surgery, 39 patients with mediastinoscopy stage 3A unresectable N2 NSCLC received induction chemotherapy with 2 cycles of mitomycin-C, vindesine and cisplatin (MVP). Responding patients underwent thoracotomy for resection and 2 further courses of MVP. The overall response rate was 64% (2539) with 3 complete and 22 partial responses. 22 patients were resected which included a radical mediastinal node dissection. 18 resections were complete and 4 were incomplete. Pathologically 3 patients (7.7%) had no tumor remaining. There were 2 post-op deaths secondary to a BP fistula. In addition to GI and neurologic side effects, toxicity of chemotherapy included mitomycin pulmonary toxicity in 2 patients and 4 septic deaths. 28 patients have died, 20 with recurrent or progressive disease. Of the 18 patients completely resected, 8 have recurred with a median time to recurrence of 20.6 months. Sites of recurrence include 2 loco-regional, 5 distant (2 in brain) and 1 both. Median survival of the entire 39 patients is 18.6 months with a 3-year survival of 26%. The median survival for those patients completely resected is 29.7 months with a 3-year survival of 40%. These findings suggest that MVP is an effective but toxic chemotherapeutic regimen for limited NSCLC, and although the median survival appears to be prolonged, the role of induction chemotherapy followed by surgery in stage IIIA N2 NSCLC requires a Phase III randomized trial comparing it to other treatment modalities." @default.
- W2066883487 created "2016-06-24" @default.
- W2066883487 creator A5000995287 @default.
- W2066883487 creator A5013594080 @default.
- W2066883487 creator A5018446991 @default.
- W2066883487 creator A5023134363 @default.
- W2066883487 creator A5034320735 @default.
- W2066883487 creator A5048361872 @default.
- W2066883487 creator A5066087487 @default.
- W2066883487 creator A5070668450 @default.
- W2066883487 creator A5075347427 @default.
- W2066883487 creator A5085440932 @default.
- W2066883487 creator A5090437990 @default.
- W2066883487 creator A5090548270 @default.
- W2066883487 date "1993-03-01" @default.
- W2066883487 modified "2023-09-26" @default.
- W2066883487 title "Induction chemotherapy with MVP (mitomycin-C + vindesine + cisplatin) for stage III (T1-3, N2, M0) unresectable non-small cell lung cancer: the Toronto experience" @default.
- W2066883487 cites W1868113641 @default.
- W2066883487 cites W1968092312 @default.
- W2066883487 cites W1989405853 @default.
- W2066883487 cites W2051767374 @default.
- W2066883487 cites W2059563719 @default.
- W2066883487 cites W2411077152 @default.
- W2066883487 cites W1564470 @default.
- W2066883487 doi "https://doi.org/10.1016/0169-5002(93)90694-s" @default.
- W2066883487 hasPublicationYear "1993" @default.
- W2066883487 type Work @default.
- W2066883487 sameAs 2066883487 @default.
- W2066883487 citedByCount "8" @default.
- W2066883487 crossrefType "journal-article" @default.
- W2066883487 hasAuthorship W2066883487A5000995287 @default.
- W2066883487 hasAuthorship W2066883487A5013594080 @default.
- W2066883487 hasAuthorship W2066883487A5018446991 @default.
- W2066883487 hasAuthorship W2066883487A5023134363 @default.
- W2066883487 hasAuthorship W2066883487A5034320735 @default.
- W2066883487 hasAuthorship W2066883487A5048361872 @default.
- W2066883487 hasAuthorship W2066883487A5066087487 @default.
- W2066883487 hasAuthorship W2066883487A5070668450 @default.
- W2066883487 hasAuthorship W2066883487A5075347427 @default.
- W2066883487 hasAuthorship W2066883487A5085440932 @default.
- W2066883487 hasAuthorship W2066883487A5090437990 @default.
- W2066883487 hasAuthorship W2066883487A5090548270 @default.
- W2066883487 hasConcept C126322002 @default.
- W2066883487 hasConcept C141071460 @default.
- W2066883487 hasConcept C143998085 @default.
- W2066883487 hasConcept C146357865 @default.
- W2066883487 hasConcept C151730666 @default.
- W2066883487 hasConcept C2776256026 @default.
- W2066883487 hasConcept C2776283816 @default.
- W2066883487 hasConcept C2776611710 @default.
- W2066883487 hasConcept C2776694085 @default.
- W2066883487 hasConcept C2776755627 @default.
- W2066883487 hasConcept C2779321808 @default.
- W2066883487 hasConcept C2779338040 @default.
- W2066883487 hasConcept C2779429289 @default.
- W2066883487 hasConcept C2781413609 @default.
- W2066883487 hasConcept C71924100 @default.
- W2066883487 hasConcept C86803240 @default.
- W2066883487 hasConcept C90924648 @default.
- W2066883487 hasConceptScore W2066883487C126322002 @default.
- W2066883487 hasConceptScore W2066883487C141071460 @default.
- W2066883487 hasConceptScore W2066883487C143998085 @default.
- W2066883487 hasConceptScore W2066883487C146357865 @default.
- W2066883487 hasConceptScore W2066883487C151730666 @default.
- W2066883487 hasConceptScore W2066883487C2776256026 @default.
- W2066883487 hasConceptScore W2066883487C2776283816 @default.
- W2066883487 hasConceptScore W2066883487C2776611710 @default.
- W2066883487 hasConceptScore W2066883487C2776694085 @default.
- W2066883487 hasConceptScore W2066883487C2776755627 @default.
- W2066883487 hasConceptScore W2066883487C2779321808 @default.
- W2066883487 hasConceptScore W2066883487C2779338040 @default.
- W2066883487 hasConceptScore W2066883487C2779429289 @default.
- W2066883487 hasConceptScore W2066883487C2781413609 @default.
- W2066883487 hasConceptScore W2066883487C71924100 @default.
- W2066883487 hasConceptScore W2066883487C86803240 @default.
- W2066883487 hasConceptScore W2066883487C90924648 @default.
- W2066883487 hasIssue "1-6" @default.
- W2066883487 hasLocation W20668834871 @default.
- W2066883487 hasOpenAccess W2066883487 @default.
- W2066883487 hasPrimaryLocation W20668834871 @default.
- W2066883487 hasVolume "9" @default.
- W2066883487 isParatext "false" @default.
- W2066883487 isRetracted "false" @default.
- W2066883487 magId "2066883487" @default.
- W2066883487 workType "article" @default.